Literature DB >> 30388976

Acute Kidney Injury.

Ashley Farrar1.   

Abstract

Acute kidney injury (AKI) most commonly occurs in the hospital setting, and hospital-acquired AKI accounts for 22% of all AKI cases worldwide. AKI causes 2 million deaths per year, and 50% of critically ill patients develop AKI. AKIs include prerenal, intrarenal, and postrenal causes. Treatments include renal replacement therapies and correcting reversible causes. Management of these patients includes medical and social history, laboratory studies, tests such as renal biopsy and ultrasonography, vital signs, volume status, and identifying risk factors. Thus, it is essential to identify high-risk patients, correct any reversible causes, prevent further kidney injury, and perform supportive therapy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury (AKI); Intrarenal; Ischemia; Obstruction; Postrenal renal perfusion; Prerenal; Renal replacement therapy

Mesh:

Year:  2018        PMID: 30388976     DOI: 10.1016/j.cnur.2018.07.001

Source DB:  PubMed          Journal:  Nurs Clin North Am        ISSN: 0029-6465            Impact factor:   1.208


  16 in total

Review 1.  Regulation of TFEB activity and its potential as a therapeutic target against kidney diseases.

Authors:  Weihuang Zhang; Xiaoyu Li; Shujun Wang; Yanse Chen; Huafeng Liu
Journal:  Cell Death Discov       Date:  2020-05-01

Review 2.  Acute kidney injury in pediatrics: an overview focusing on pathophysiology.

Authors:  Ana Flávia Lima Ruas; Gabriel Malheiros Lébeis; Nicholas Bianco de Castro; Vitória Andrade Palmeira; Larissa Braga Costa; Katharina Lanza; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2021-11-30       Impact factor: 3.651

3.  Falsely Elevated Creatinine on Enzymatic Assay in a Patient Receiving Subcutaneous IgG Therapy.

Authors:  Ashley R Santilli; Mark L Wieland
Journal:  J Gen Intern Med       Date:  2021-02-05       Impact factor: 5.128

4.  Exosome-mediated pyroptosis of miR-93-TXNIP-NLRP3 leads to functional difference between M1 and M2 macrophages in sepsis-induced acute kidney injury.

Authors:  Chen-Xia Juan; Yan Mao; Qian Cao; Yan Chen; Lan-Bo Zhou; Sheng Li; Hao Chen; Jia-He Chen; Guo-Ping Zhou; Rui Jin
Journal:  J Cell Mol Med       Date:  2021-03-21       Impact factor: 5.310

5.  Hypoglycemic and Toxic Effect of Morus mesozygia Leaf Extract on the Liver and Kidneys of Alloxan-Induced Hyperglycemic Wistar Rats.

Authors:  Michael Tirwomwe; Isaac Echoru; Richard Maseruka; Kyobe Ronald Kimanje; Wilson Byarugaba
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-19       Impact factor: 2.629

6.  Formononetin protects against cisplatin‑induced acute kidney injury through activation of the PPARα/Nrf2/HO‑1/NQO1 pathway.

Authors:  Yan Hao; Jie Miao; Wenjia Liu; Li Peng; Yue Chen; Qing Zhong
Journal:  Int J Mol Med       Date:  2020-12-01       Impact factor: 4.101

Review 7.  The value of kidney injury molecule 1 in predicting acute kidney injury in adult patients: a systematic review and Bayesian meta-analysis.

Authors:  Jiwen Geng; Yuxuan Qiu; Zheng Qin; Baihai Su
Journal:  J Transl Med       Date:  2021-03-12       Impact factor: 5.531

Review 8.  Regulation of TFEB activity and its potential as a therapeutic target against kidney diseases.

Authors:  Weihuang Zhang; Xiaoyu Li; Shujun Wang; Yanse Chen; Huafeng Liu
Journal:  Cell Death Discov       Date:  2020-05-01

9.  Eleutheroside B Protects against Acute Kidney Injury by Activating IGF Pathway.

Authors:  Hongmei Zang; Qin Yang; Jun Li
Journal:  Molecules       Date:  2019-10-28       Impact factor: 4.411

Review 10.  Fighting Oxidative Stress with Sulfur: Hydrogen Sulfide in the Renal and Cardiovascular Systems.

Authors:  Joshua J Scammahorn; Isabel T N Nguyen; Eelke M Bos; Harry Van Goor; Jaap A Joles
Journal:  Antioxidants (Basel)       Date:  2021-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.